343 related articles for article (PubMed ID: 19560881)
1. Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
Spoelstra FO; Senan S; Le Péchoux C; Ishikura S; Casas F; Ball D; Price A; De Ruysscher D; van Sörnsen de Koste JR;
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1106-13. PubMed ID: 19560881
[TBL] [Abstract][Full Text] [Related]
2. Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III NSCLC.
van Sörnsen de Koste JR; Senan S; Underberg RW; Oei SS; Elshove D; Slotman BJ; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):334-9. PubMed ID: 16168828
[TBL] [Abstract][Full Text] [Related]
3. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
Senan S; van Sörnsen de Koste J; Samson M; Tankink H; Jansen P; Nowak PJ; Krol AD; Schmitz P; Lagerwaard FJ
Radiother Oncol; 1999 Dec; 53(3):247-55. PubMed ID: 10660205
[TBL] [Abstract][Full Text] [Related]
5. Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
Cui Y; Chen W; Kong FM; Olsen LA; Beatty RE; Maxim PG; Ritter T; Sohn JW; Higgins J; Galvin JM; Xiao Y
Pract Radiat Oncol; 2015; 5(2):e67-75. PubMed ID: 25413413
[TBL] [Abstract][Full Text] [Related]
6. A comparison of internal target volume definition by limited four-dimensional computed tomography, the addition of patient-specific margins, or the addition of generic margins when planning radical radiotherapy for lymph node-positive non-small cell lung cancer.
Hughes S; McClelland J; Chandler A; Adams M; Boutland J; Withers D; Ahmad S; Blackall J; Tarte S; Hawkes D; Landau D
Clin Oncol (R Coll Radiol); 2008 May; 20(4):293-300. PubMed ID: 18234482
[TBL] [Abstract][Full Text] [Related]
7. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
8. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
9. ProCaLung - Peer review in stage III, mediastinal node-positive, non-small-cell lung cancer: How to benchmark clinical practice of nodal target volume definition and delineation in Belgium
Charlier F; Descamps T; Lievens Y; Geets X; Remouchamps V; Lambrecht M; Moretti L
Radiother Oncol; 2022 Feb; 167():57-64. PubMed ID: 34890738
[TBL] [Abstract][Full Text] [Related]
10. Patterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume design.
Feng W; Fu XL; Cai XW; Yang HJ; Wu KL; Fan M; Xiang JQ; Zhang YW; Chen HQ
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1100-7. PubMed ID: 24529715
[TBL] [Abstract][Full Text] [Related]
11. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
12. Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.
Videtic GM; Rice TW; Murthy S; Suh JH; Saxton JP; Adelstein DJ; Mekhail TM
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):702-6. PubMed ID: 18374513
[TBL] [Abstract][Full Text] [Related]
13. A simplified CT-based definition of the supraclavicular and infraclavicular nodal volumes in breast cancer.
Atean I; Pointreau Y; Ouldamer L; Monghal C; Bougnoux A; Bera G; Barillot I
Cancer Radiother; 2013 Feb; 17(1):39-43. PubMed ID: 23333457
[TBL] [Abstract][Full Text] [Related]
14. Impact of Peer Review in Reducing Uncertainty in the Definition of the Lung Target Volume Among Trainee Oncologists.
Mercieca S; Pan S; Belderbos J; Salem A; Tenant S; Aznar MC; Woolf D; Radhakrishna G; van Herk M
Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):363-372. PubMed ID: 32033892
[TBL] [Abstract][Full Text] [Related]
15. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
16. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.
Nielsen MH; Berg M; Pedersen AN; Andersen K; Glavicic V; Jakobsen EH; Jensen I; Josipovic M; Lorenzen EL; Nielsen HM; Stenbygaard L; Thomsen MS; Vallentin S; Zimmermann S; Offersen BV;
Acta Oncol; 2013 May; 52(4):703-10. PubMed ID: 23421926
[TBL] [Abstract][Full Text] [Related]
17. Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma.
Piva C; Genovesi D; Filippi AR; Balducci M; Barra S; Buglione M; Busetto M; Ciammella P; Franzone P; De Sanctis V; Simontacchi G; Fusella M; Ricardi U;
Pract Radiat Oncol; 2015; 5(6):383-9. PubMed ID: 26547826
[TBL] [Abstract][Full Text] [Related]
18. The impact of peer review of volume delineation in stereotactic body radiation therapy planning for primary lung cancer: a multicenter quality assurance study.
Lo AC; Liu M; Chan E; Lund C; Truong PT; Loewen S; Cao J; Schellenberg D; Carolan H; Berrang T; Wu J; Berthelet E; Olson R
J Thorac Oncol; 2014 Apr; 9(4):527-33. PubMed ID: 24736076
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
